By: Gretchen Stipec, M.D., radiologist, Cancer Institute, Long Beach Medical Center Seniors account for nearly 28% of all new ...

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.) The integration will help streamline the process of ordering the Galleri test ...

We recently published 10 Market Stars Behind Millionaire-Making in 2025. Grail Inc. (NASDAQ:GRAL) is one of the top performers. Grail Inc. soared by 379.5 percent in 2025, with the rally primarily ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Grail (NASDAQ:GRAL) announced Wednesday that its Galleri test led to improved cancer detection when added to standard-of-care cancer screening in its PATHFINDER 2 registrational trial. Citing topline ...

MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.) GRAIL’s Galleri Test Now Directly Available to Physicians in the U.S. Through ...